Background Treatment guidelines recommend the use of inhaled corticosteroids in patients
with asthma who have persistent symptoms and the “stepping down” of therapy to the …

PURPOSE: To determine whether montelukast is as effective as fluticasone in controlling
mild persistent asthma as determined by rescue-free days. SUBJECTS AND METHODS …

Objective To compare the long-term effects of an inhaled corticosteroid with those of a
leukotriene modifier on measures of clinical efficacy, subject preference, and safety in …

Background: Both inhaled corticosteroids and leukotriene modifiers are used in the
maintenance treatment of persistent asthma. Objective: The goal was to compare the …

BACKGROUND: Asthma is a chronic disease characterized by inflammation and
bronchoconstriction. Medications that are able to effectively treat both components are …

Background Although guidelines recommend daily therapy for patients with mild persistent
asthma, prescription patterns suggest that most such patients use these so-called controller …

ContextLong-acting β2-agonists are prescribed for patients with persistent asthma and are
sometimes used without inhaled corticosteroids (ICSs). No evidence exists, however, to …

Background Although inhaled glucocorticosteroids are recommended for persistent asthma,
their long-term effect on recent onset, mild, persistent asthma has yet to be established …

Background: Few studies have compared the efficacy of inhaled corticosteroids and
leukotriene modifiers for the treatment of persistent asthma. Objective: Our purpose was to …

Patients with mild persistent asthma rarely see their doctor with symptoms of the disease.
Partly as a result of this situation, mild asthma is generally undertreated. Findings of several …